Reuters logo
BRIEF-J&J diabetes care company Animas to close operations and exit insulin pump market
October 5, 2017 / 11:20 AM / in 12 days

BRIEF-J&J diabetes care company Animas to close operations and exit insulin pump market

Oct 5 (Reuters) - Johnson & Johnson:

* ‍Johnson & Johnson Diabetes Care Companies - Animas corp intends to discontinue manufacturing, sale of animas vibe and onetouch ping insulin pumps

* ‍Johnson & Johnson Diabetes Care Companies - Animas corp also intends to close operations and exit insulin pump business​

* ‍Johnson & Johnson Diabetes Care Companies - Animas selected Medtronic as partner to facilitate transition for patients, caregivers, healthcare providers​

* ‍Johnson & Johnson Diabetes Care Companies - patients using an Animas insulin pump will be offered option to transfer to a Medtronic pump​

* ‍Johnson & Johnson Diabetes Care Companies - Johnson & Johnson is continuing to evaluate potential strategic options for Lifescan Inc​

* ‍Johnson & Johnson Diabetes Care Companies - for patients, healthcare providers outside of U.S., Canada Animas to continue to sell pumps, operate as usual​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below